

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of guanylate cyclase activity (GO:0031284) | 9.95962999 |
| 2 | retinal rod cell development (GO:0046548) | 8.98807165 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 8.98235663 |
| 4 | GMP metabolic process (GO:0046037) | 8.97975168 |
| 5 | * visual perception (GO:0007601) | 8.51854724 |
| 6 | * sensory perception of light stimulus (GO:0050953) | 8.42276866 |
| 7 | cellular response to light stimulus (GO:0071482) | 7.35466670 |
| 8 | detection of external stimulus (GO:0009581) | 7.09439405 |
| 9 | detection of abiotic stimulus (GO:0009582) | 6.96040382 |
| 10 | eye photoreceptor cell differentiation (GO:0001754) | 6.67509111 |
| 11 | photoreceptor cell differentiation (GO:0046530) | 6.67509111 |
| 12 | regulation of cGMP metabolic process (GO:0030823) | 6.21588649 |
| 13 | retina development in camera-type eye (GO:0060041) | 6.21542100 |
| 14 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 6.01130984 |
| 15 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.79630865 |
| 16 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.70902159 |
| 17 | regulation of cGMP biosynthetic process (GO:0030826) | 5.43038167 |
| 18 | positive regulation of cGMP metabolic process (GO:0030825) | 5.12810553 |
| 19 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 4.88115735 |
| 20 | cellular response to radiation (GO:0071478) | 4.77091895 |
| 21 | nonmotile primary cilium assembly (GO:0035058) | 4.65247046 |
| 22 | response to electrical stimulus (GO:0051602) | 4.65138847 |
| 23 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.60951125 |
| 24 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.58220676 |
| 25 | adaptation of signaling pathway (GO:0023058) | 4.57073289 |
| 26 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.53392321 |
| 27 | negative regulation of heart growth (GO:0061117) | 4.53392321 |
| 28 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.47887911 |
| 29 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.39455615 |
| 30 | negative regulation of muscle hypertrophy (GO:0014741) | 4.32006465 |
| 31 | estrogen biosynthetic process (GO:0006703) | 4.13004987 |
| 32 | * sensory perception (GO:0007600) | 4.04210623 |
| 33 | retinal metabolic process (GO:0042574) | 4.00339977 |
| 34 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.99238385 |
| 35 | response to light stimulus (GO:0009416) | 3.87293494 |
| 36 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.83619520 |
| 37 | retina layer formation (GO:0010842) | 3.80000613 |
| 38 | neuron development (GO:0048666) | 3.56060627 |
| 39 | short-term memory (GO:0007614) | 3.53289370 |
| 40 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.52913074 |
| 41 | protein prenylation (GO:0018342) | 3.52800038 |
| 42 | prenylation (GO:0097354) | 3.52800038 |
| 43 | behavioral response to ethanol (GO:0048149) | 3.51390867 |
| 44 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.42169793 |
| 45 | regulation of penile erection (GO:0060405) | 3.38449958 |
| 46 | positive regulation of neurotransmitter transport (GO:0051590) | 3.37907167 |
| 47 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.37331113 |
| 48 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.34085852 |
| 49 | chemosensory behavior (GO:0007635) | 3.33443716 |
| 50 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.32321847 |
| 51 | response to histamine (GO:0034776) | 3.30587728 |
| 52 | fat-soluble vitamin metabolic process (GO:0006775) | 3.30242975 |
| 53 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.27299492 |
| 54 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.27299492 |
| 55 | multicellular organism reproduction (GO:0032504) | 3.24230638 |
| 56 | membrane hyperpolarization (GO:0060081) | 3.23308686 |
| 57 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.22481437 |
| 58 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 3.21346235 |
| 59 | retina homeostasis (GO:0001895) | 3.17915901 |
| 60 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.17786565 |
| 61 | sensory perception of taste (GO:0050909) | 3.15420932 |
| 62 | negative regulation of cardiac muscle tissue development (GO:0055026) | 3.15179034 |
| 63 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.13475631 |
| 64 | retinoid metabolic process (GO:0001523) | 3.11085116 |
| 65 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.06231823 |
| 66 | protein localization to synapse (GO:0035418) | 3.04053440 |
| 67 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.01936227 |
| 68 | inner ear receptor cell differentiation (GO:0060113) | 2.98962025 |
| 69 | diterpenoid metabolic process (GO:0016101) | 2.87931915 |
| 70 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.85125095 |
| 71 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.84411630 |
| 72 | phospholipid translocation (GO:0045332) | 2.84035443 |
| 73 | lipid translocation (GO:0034204) | 2.84035443 |
| 74 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.83173980 |
| 75 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.81177956 |
| 76 | negative regulation of catenin import into nucleus (GO:0035414) | 2.78766099 |
| 77 | sperm motility (GO:0030317) | 2.77139159 |
| 78 | homocysteine metabolic process (GO:0050667) | 2.73284478 |
| 79 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.68127743 |
| 80 | response to radiation (GO:0009314) | 2.66492963 |
| 81 | isoprenoid metabolic process (GO:0006720) | 2.65758833 |
| 82 | post-embryonic morphogenesis (GO:0009886) | 2.64904086 |
| 83 | terpenoid metabolic process (GO:0006721) | 2.62371595 |
| 84 | righting reflex (GO:0060013) | 2.61921947 |
| 85 | synaptic vesicle maturation (GO:0016188) | 2.59531326 |
| 86 | behavioral response to cocaine (GO:0048148) | 2.58164540 |
| 87 | ovulation from ovarian follicle (GO:0001542) | 2.57545055 |
| 88 | axoneme assembly (GO:0035082) | 2.56115341 |
| 89 | microtubule nucleation (GO:0007020) | 2.55808604 |
| 90 | cellular response to zinc ion (GO:0071294) | 2.55774233 |
| 91 | negative regulation of cation channel activity (GO:2001258) | 2.54183914 |
| 92 | icosanoid secretion (GO:0032309) | 2.54160621 |
| 93 | arachidonic acid secretion (GO:0050482) | 2.54160621 |
| 94 | reproduction (GO:0000003) | 2.53874165 |
| 95 | dopamine receptor signaling pathway (GO:0007212) | 2.52477578 |
| 96 | startle response (GO:0001964) | 2.50821270 |
| 97 | synaptic transmission, dopaminergic (GO:0001963) | 2.50175371 |
| 98 | positive regulation of cyclase activity (GO:0031281) | 2.49712741 |
| 99 | smooth muscle tissue development (GO:0048745) | 2.48899106 |
| 100 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.48882078 |
| 101 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.48882078 |
| 102 | glycine transport (GO:0015816) | 2.47580332 |
| 103 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.47354216 |
| 104 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.46699291 |
| 105 | acrosome reaction (GO:0007340) | 2.45239833 |
| 106 | cellular response to abiotic stimulus (GO:0071214) | 2.41936641 |
| 107 | retinol metabolic process (GO:0042572) | 2.41300947 |
| 108 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.38860529 |
| 109 | protein heterotetramerization (GO:0051290) | 2.38076973 |
| 110 | white fat cell differentiation (GO:0050872) | 2.37264099 |
| 111 | regulation of plasminogen activation (GO:0010755) | 2.35567945 |
| 112 | regulation of muscle hypertrophy (GO:0014743) | 2.34859430 |
| 113 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.34294003 |
| 114 | mechanoreceptor differentiation (GO:0042490) | 2.33052878 |
| 115 | regulation of endothelial cell differentiation (GO:0045601) | 2.29061036 |
| 116 | regulation of neurotransmitter uptake (GO:0051580) | 2.28391560 |
| 117 | positive regulation of lyase activity (GO:0051349) | 2.28385951 |
| 118 | gamma-aminobutyric acid transport (GO:0015812) | 2.24831274 |
| 119 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.19760904 |
| 120 | positive regulation of gastrulation (GO:2000543) | 2.18983404 |
| 121 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.17276582 |
| 122 | cochlea development (GO:0090102) | 2.14611920 |
| 123 | regulation of muscle adaptation (GO:0043502) | 2.12965895 |
| 124 | calcium ion-dependent exocytosis (GO:0017156) | 2.11058763 |
| 125 | single fertilization (GO:0007338) | 2.09365349 |
| 126 | establishment of protein localization to Golgi (GO:0072600) | 2.07666116 |
| 127 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.06924200 |
| 128 | regulation of lipoprotein metabolic process (GO:0050746) | 2.06221654 |
| 129 | hair cell differentiation (GO:0035315) | 2.05561472 |
| 130 | cell migration involved in heart development (GO:0060973) | 2.04991401 |
| 131 | modified amino acid transport (GO:0072337) | 2.04137655 |
| 132 | cranial nerve morphogenesis (GO:0021602) | 2.03950276 |
| 133 | keratan sulfate catabolic process (GO:0042340) | 2.03122963 |
| 134 | sperm-egg recognition (GO:0035036) | 2.02901473 |
| 135 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 18.1044502 |
| 136 | rhodopsin mediated signaling pathway (GO:0016056) | 17.6601994 |
| 137 | retinal cone cell development (GO:0046549) | 16.5024973 |
| 138 | vitamin A metabolic process (GO:0006776) | 14.3809316 |
| 139 | photoreceptor cell development (GO:0042461) | 11.9759073 |
| 140 | photoreceptor cell maintenance (GO:0045494) | 11.6523308 |
| 141 | eye photoreceptor cell development (GO:0042462) | 11.5130835 |
| 142 | cellular response to electrical stimulus (GO:0071257) | 11.4682205 |
| 143 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.2700340 |
| 144 | detection of light stimulus involved in visual perception (GO:0050908) | 11.2700340 |
| 145 | phototransduction (GO:0007602) | 10.7182108 |
| 146 | phototransduction, visible light (GO:0007603) | 10.6499137 |
| 147 | protein-chromophore linkage (GO:0018298) | 10.5658796 |
| 148 | detection of visible light (GO:0009584) | 10.1598689 |
| 149 | detection of light stimulus (GO:0009583) | 10.0992296 |
| 150 | regulation of cyclase activity (GO:0031279) | 1.99852965 |
| 151 | sperm capacitation (GO:0048240) | 1.99822320 |
| 152 | regulation of female gonad development (GO:2000194) | 1.98985055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.24759123 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.01683279 |
| 3 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.57404800 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.49296088 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.21988308 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.19163894 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33446382 |
| 8 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.32755251 |
| 9 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10858906 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.06098795 |
| 11 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.03585712 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.97520835 |
| 13 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.92152011 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89180629 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.88368251 |
| 16 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.75569350 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75489668 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.73533394 |
| 19 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.73318539 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.71906999 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.71761364 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.67824534 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64883705 |
| 24 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63635268 |
| 25 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.63015627 |
| 26 | AR_25329375_ChIP-Seq_VCAP_Human | 1.60093699 |
| 27 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.60030958 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.58313797 |
| 29 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.57946986 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57923810 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56652156 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55799460 |
| 33 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.55459699 |
| 34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.55459699 |
| 35 | CJUN_26792858_Chip-Seq_BT549_Human | 1.53213528 |
| 36 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52551667 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.52115712 |
| 38 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50944495 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.50804546 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.50804546 |
| 41 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49649470 |
| 42 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.49166977 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46904071 |
| 44 | * AR_19668381_ChIP-Seq_PC3_Human | 1.46211999 |
| 45 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44490129 |
| 46 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43791259 |
| 47 | RXR_22108803_ChIP-Seq_LS180_Human | 1.43265402 |
| 48 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41501074 |
| 49 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40920434 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38123870 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.37061437 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37019837 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36390160 |
| 54 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36256558 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36164679 |
| 56 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.36109037 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34738565 |
| 58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.34084750 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31823882 |
| 60 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.31332309 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31239456 |
| 62 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.30296060 |
| 63 | TBL1_22424771_ChIP-Seq_293T_Human | 1.28881535 |
| 64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28752622 |
| 65 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.28594391 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28141370 |
| 67 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.27212343 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25753279 |
| 69 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25105953 |
| 70 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24545934 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23630136 |
| 72 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20945650 |
| 73 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.19864444 |
| 74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18309157 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17858603 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16542078 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15180502 |
| 78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15009324 |
| 79 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13502720 |
| 80 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12125489 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11596650 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11593414 |
| 83 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10917938 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10483511 |
| 85 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10015670 |
| 86 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08863173 |
| 87 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.08785137 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08654409 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08105171 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07227652 |
| 91 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06131942 |
| 92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05839334 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05582303 |
| 94 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05549098 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04968443 |
| 96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04854575 |
| 97 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04716275 |
| 98 | NFYB_21822215_ChIP-Seq_K562_Human | 1.04189261 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04162014 |
| 100 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01997681 |
| 101 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01663176 |
| 102 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00956448 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00757903 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00609237 |
| 105 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99609665 |
| 106 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.98636215 |
| 107 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98273482 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98256413 |
| 109 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97843952 |
| 110 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97273101 |
| 111 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97199797 |
| 112 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96863779 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96840738 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96279191 |
| 115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96261418 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96200382 |
| 117 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95989132 |
| 118 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95864753 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94095227 |
| 120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94041648 |
| 121 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93966070 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93777628 |
| 123 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93777628 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93476009 |
| 125 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.93227857 |
| 126 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.91603228 |
| 127 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91080119 |
| 128 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88677137 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88366511 |
| 130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.87973073 |
| 131 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87913514 |
| 132 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87324685 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87306304 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86673208 |
| 135 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.86448290 |
| 136 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86380026 |
| 137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86046014 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85325129 |
| 139 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.85062022 |
| 140 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84898471 |
| 141 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84730634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 9.84917208 |
| 2 | MP0005253_abnormal_eye_physiology | 6.86568213 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.37169128 |
| 4 | MP0005195_abnormal_posterior_eye | 3.85214428 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.70805494 |
| 6 | MP0001324_abnormal_eye_pigmentation | 3.42923124 |
| 7 | MP0005391_vision/eye_phenotype | 3.31628687 |
| 8 | MP0002090_abnormal_vision | 3.06610033 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.86943432 |
| 10 | MP0002229_neurodegeneration | 2.68543803 |
| 11 | MP0002638_abnormal_pupillary_reflex | 2.60399052 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.28621911 |
| 13 | MP0003011_delayed_dark_adaptation | 11.0193066 |
| 14 | MP0002752_abnormal_somatic_nervous | 1.95828374 |
| 15 | MP0001764_abnormal_homeostasis | 1.91205924 |
| 16 | MP0001346_abnormal_lacrimal_gland | 1.78034437 |
| 17 | MP0002653_abnormal_ependyma_morphology | 1.50792172 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.49362769 |
| 19 | MP0005410_abnormal_fertilization | 1.44046651 |
| 20 | MP0002882_abnormal_neuron_morphology | 1.41781022 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.18747246 |
| 22 | MP0004233_abnormal_muscle_weight | 1.16355472 |
| 23 | MP0001502_abnormal_circadian_rhythm | 1.12484659 |
| 24 | MP0001984_abnormal_olfaction | 1.03170385 |
| 25 | MP0002822_catalepsy | 1.02223608 |
| 26 | MP0001486_abnormal_startle_reflex | 1.01880668 |
| 27 | MP0004270_analgesia | 1.01163325 |
| 28 | MP0004885_abnormal_endolymph | 1.00433336 |
| 29 | MP0005377_hearing/vestibular/ear_phenot | 0.92300091 |
| 30 | MP0003878_abnormal_ear_physiology | 0.92300091 |
| 31 | MP0006292_abnormal_olfactory_placode | 0.92211964 |
| 32 | MP0005197_abnormal_uvea_morphology | 0.90343355 |
| 33 | MP0010368_abnormal_lymphatic_system | 0.88928229 |
| 34 | MP0005670_abnormal_white_adipose | 0.86071843 |
| 35 | MP0003880_abnormal_central_pattern | 0.84454618 |
| 36 | MP0001485_abnormal_pinna_reflex | 0.83249644 |
| 37 | MP0002332_abnormal_exercise_endurance | 0.83247021 |
| 38 | MP0005360_urolithiasis | 0.82922345 |
| 39 | MP0002272_abnormal_nervous_system | 0.82283434 |
| 40 | MP0005394_taste/olfaction_phenotype | 0.80098390 |
| 41 | MP0005499_abnormal_olfactory_system | 0.80098390 |
| 42 | MP0008995_early_reproductive_senescence | 0.78142195 |
| 43 | MP0003879_abnormal_hair_cell | 0.76221405 |
| 44 | MP0003136_yellow_coat_color | 0.75875478 |
| 45 | MP0002127_abnormal_cardiovascular_syste | 0.74760248 |
| 46 | MP0003634_abnormal_glial_cell | 0.70773676 |
| 47 | MP0000566_synostosis | 0.70323530 |
| 48 | MP0004859_abnormal_synaptic_plasticity | 0.67297196 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 0.65492281 |
| 50 | MP0002064_seizures | 0.65046497 |
| 51 | MP0010030_abnormal_orbit_morphology | 0.64222163 |
| 52 | MP0002734_abnormal_mechanical_nocicepti | 0.63857292 |
| 53 | MP0008789_abnormal_olfactory_epithelium | 0.63736389 |
| 54 | MP0009046_muscle_twitch | 0.62791498 |
| 55 | MP0003635_abnormal_synaptic_transmissio | 0.62150572 |
| 56 | MP0003718_maternal_effect | 0.60183016 |
| 57 | MP0002009_preneoplasia | 0.59011212 |
| 58 | MP0001963_abnormal_hearing_physiology | 0.58419533 |
| 59 | MP0000516_abnormal_urinary_system | 0.56094382 |
| 60 | MP0005367_renal/urinary_system_phenotyp | 0.56094382 |
| 61 | MP0001968_abnormal_touch/_nociception | 0.53804628 |
| 62 | MP0001286_abnormal_eye_development | 0.53475829 |
| 63 | MP0000534_abnormal_ureter_morphology | 0.53406475 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 0.53212047 |
| 65 | MP0005187_abnormal_penis_morphology | 0.52028301 |
| 66 | MP0008004_abnormal_stomach_pH | 0.51827051 |
| 67 | MP0006276_abnormal_autonomic_nervous | 0.51799770 |
| 68 | MP0002063_abnormal_learning/memory/cond | 0.51257951 |
| 69 | MP0002067_abnormal_sensory_capabilities | 0.49899783 |
| 70 | MP0003698_abnormal_male_reproductive | 0.49809898 |
| 71 | MP0005503_abnormal_tendon_morphology | 0.49728901 |
| 72 | MP0004742_abnormal_vestibular_system | 0.49565515 |
| 73 | MP0005386_behavior/neurological_phenoty | 0.49150675 |
| 74 | MP0004924_abnormal_behavior | 0.49150675 |
| 75 | MP0009745_abnormal_behavioral_response | 0.48962417 |
| 76 | MP0002735_abnormal_chemical_nociception | 0.48114685 |
| 77 | MP0001756_abnormal_urination | 0.46136938 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.46102476 |
| 79 | MP0002282_abnormal_trachea_morphology | 0.44146316 |
| 80 | MP0005275_abnormal_skin_tensile | 0.42278456 |
| 81 | MP0003045_fibrosis | 0.41352272 |
| 82 | MP0002102_abnormal_ear_morphology | 0.39593329 |
| 83 | MP0005647_abnormal_sex_gland | 0.38750224 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.38720495 |
| 85 | MP0002295_abnormal_pulmonary_circulatio | 0.38490870 |
| 86 | MP0001929_abnormal_gametogenesis | 0.36749905 |
| 87 | MP0005395_other_phenotype | 0.35960612 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.34860117 |
| 89 | MP0009780_abnormal_chondrocyte_physiolo | 0.33761921 |
| 90 | MP0005171_absent_coat_pigmentation | 0.33728855 |
| 91 | MP0000026_abnormal_inner_ear | 0.32098685 |
| 92 | MP0004142_abnormal_muscle_tone | 0.32093429 |
| 93 | MP0004085_abnormal_heartbeat | 0.31892863 |
| 94 | MP0005620_abnormal_muscle_contractility | 0.30369138 |
| 95 | MP0000427_abnormal_hair_cycle | 0.30143545 |
| 96 | MP0000647_abnormal_sebaceous_gland | 0.30129091 |
| 97 | MP0002160_abnormal_reproductive_system | 0.29318613 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.29205696 |
| 99 | MP0002161_abnormal_fertility/fecundity | 0.28996058 |
| 100 | MP0008569_lethality_at_weaning | 0.28349040 |
| 101 | MP0002938_white_spotting | 0.27811360 |
| 102 | MP0004782_abnormal_surfactant_physiolog | 0.27423785 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 0.27349561 |
| 104 | MP0004145_abnormal_muscle_electrophysio | 0.26628611 |
| 105 | MP0001905_abnormal_dopamine_level | 0.26242114 |
| 106 | MP0005332_abnormal_amino_acid | 0.26055278 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.25165784 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.24940187 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.24810335 |
| 110 | MP0003646_muscle_fatigue | 0.24530203 |
| 111 | MP0001299_abnormal_eye_distance/ | 0.24418525 |
| 112 | MP0002168_other_aberrant_phenotype | 0.24278238 |
| 113 | MP0002184_abnormal_innervation | 0.23820088 |
| 114 | MP0000013_abnormal_adipose_tissue | 0.23799976 |
| 115 | MP0000653_abnormal_sex_gland | 0.23594015 |
| 116 | MP0002152_abnormal_brain_morphology | 0.22773859 |
| 117 | MP0002557_abnormal_social/conspecific_i | 0.21881633 |
| 118 | MP0005646_abnormal_pituitary_gland | 0.21826316 |
| 119 | MP0000778_abnormal_nervous_system | 0.21522876 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.20987420 |
| 121 | MP0003890_abnormal_embryonic-extraembry | 0.20505717 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.20235299 |
| 123 | MP0001661_extended_life_span | 0.19127503 |
| 124 | MP0004811_abnormal_neuron_physiology | 0.18899891 |
| 125 | MP0005595_abnormal_vascular_smooth | 0.18348510 |
| 126 | MP0001501_abnormal_sleep_pattern | 0.18281688 |
| 127 | MP0002697_abnormal_eye_size | 0.17708098 |
| 128 | MP0005076_abnormal_cell_differentiation | 0.16503302 |
| 129 | MP0001915_intracranial_hemorrhage | 0.15901943 |
| 130 | MP0001970_abnormal_pain_threshold | 0.15479416 |
| 131 | MP0005193_abnormal_anterior_eye | 0.15299051 |
| 132 | MP0002928_abnormal_bile_duct | 0.14665987 |
| 133 | MP0004043_abnormal_pH_regulation | 0.14022704 |
| 134 | MP0003943_abnormal_hepatobiliary_system | 0.13580103 |
| 135 | MP0003638_abnormal_response/metabolism_ | 0.13439340 |
| 136 | MP0003632_abnormal_nervous_system | 0.13281781 |
| 137 | MP0003633_abnormal_nervous_system | 0.13202229 |
| 138 | MP0003252_abnormal_bile_duct | 0.13116075 |
| 139 | MP0001177_atelectasis | 0.12712124 |
| 140 | MP0005330_cardiomyopathy | 0.12029333 |
| 141 | MP0002972_abnormal_cardiac_muscle | 0.10905265 |
| 142 | MP0001188_hyperpigmentation | 0.10817633 |
| 143 | MP0003631_nervous_system_phenotype | 0.10450966 |
| 144 | MP0001879_abnormal_lymphatic_vessel | 0.09812049 |
| 145 | MP0005310_abnormal_salivary_gland | 0.09485673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal rod and cone electroretinograms (HP:0008323) | 9.78655680 |
| 2 | Pigmentary retinal degeneration (HP:0001146) | 9.02362863 |
| 3 | Central scotoma (HP:0000603) | 8.65467767 |
| 4 | Abnormality of macular pigmentation (HP:0008002) | 8.37092509 |
| 5 | Chorioretinal atrophy (HP:0000533) | 7.95262023 |
| 6 | Scotoma (HP:0000575) | 7.70143398 |
| 7 | Pendular nystagmus (HP:0012043) | 7.67979349 |
| 8 | Attenuation of retinal blood vessels (HP:0007843) | 7.66499122 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 6.73556473 |
| 10 | Decreased central vision (HP:0007663) | 6.62986074 |
| 11 | Photophobia (HP:0000613) | 5.85765454 |
| 12 | Type II diabetes mellitus (HP:0005978) | 5.57575830 |
| 13 | Vitreoretinal degeneration (HP:0000655) | 5.31268489 |
| 14 | Macular degeneration (HP:0000608) | 5.30451287 |
| 15 | Posterior subcapsular cataract (HP:0007787) | 5.07105384 |
| 16 | Severe visual impairment (HP:0001141) | 5.00234103 |
| 17 | Cone-rod dystrophy (HP:0000548) | 4.73583959 |
| 18 | Keratoconus (HP:0000563) | 4.65066293 |
| 19 | Increased corneal curvature (HP:0100692) | 4.65066293 |
| 20 | Constricted visual fields (HP:0001133) | 4.48009048 |
| 21 | Retinitis pigmentosa (HP:0000510) | 4.31612168 |
| 22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.70341458 |
| 23 | Progressive visual loss (HP:0000529) | 3.24732711 |
| 24 | Subcapsular cataract (HP:0000523) | 3.10321511 |
| 25 | Action tremor (HP:0002345) | 3.07211993 |
| 26 | Congenital sensorineural hearing impairment (HP:0008527) | 3.02884180 |
| 27 | Retinal atrophy (HP:0001105) | 2.98241575 |
| 28 | Optic disc pallor (HP:0000543) | 2.62741096 |
| 29 | Abnormality of alanine metabolism (HP:0010916) | 2.59826101 |
| 30 | Hyperalaninemia (HP:0003348) | 2.59826101 |
| 31 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59826101 |
| 32 | Wide nasal bridge (HP:0000431) | 2.48562674 |
| 33 | * Choroideremia (HP:0001139) | 2.44545621 |
| 34 | Gait imbalance (HP:0002141) | 2.22475737 |
| 35 | Congenital primary aphakia (HP:0007707) | 2.21489019 |
| 36 | Ulnar claw (HP:0001178) | 2.13441680 |
| 37 | Congenital stationary night blindness (HP:0007642) | 14.5464016 |
| 38 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.6326640 |
| 39 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.5685973 |
| 40 | Dyschromatopsia (HP:0007641) | 10.1216906 |
| 41 | White forelock (HP:0002211) | 1.99442917 |
| 42 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97203888 |
| 43 | Insidious onset (HP:0003587) | 1.94593855 |
| 44 | Termporal pattern (HP:0011008) | 1.94593855 |
| 45 | Hypopigmentation of the fundus (HP:0007894) | 1.92339987 |
| 46 | Medial flaring of the eyebrow (HP:0010747) | 1.88237960 |
| 47 | Tubulointerstitial nephritis (HP:0001970) | 1.88129025 |
| 48 | Birth length less than 3rd percentile (HP:0003561) | 1.83311249 |
| 49 | Upper limb muscle weakness (HP:0003484) | 1.76136325 |
| 50 | Horizontal nystagmus (HP:0000666) | 1.75333749 |
| 51 | Patchy hypopigmentation of hair (HP:0011365) | 1.72948293 |
| 52 | Potter facies (HP:0002009) | 1.71122314 |
| 53 | Facial shape deformation (HP:0011334) | 1.71122314 |
| 54 | Polar cataract (HP:0010696) | 1.70652000 |
| 55 | Poor coordination (HP:0002370) | 1.69055424 |
| 56 | Esophageal varix (HP:0002040) | 1.68530027 |
| 57 | Hypoplasia of the iris (HP:0007676) | 1.65660958 |
| 58 | Lip pit (HP:0100267) | 1.63444760 |
| 59 | True hermaphroditism (HP:0010459) | 1.61780024 |
| 60 | Spontaneous abortion (HP:0005268) | 1.60578354 |
| 61 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.58443525 |
| 62 | Optic atrophy (HP:0000648) | 1.58148218 |
| 63 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.57935142 |
| 64 | Hypoplastic ischia (HP:0003175) | 1.53672353 |
| 65 | Vaginal atresia (HP:0000148) | 1.53223264 |
| 66 | Abnormality of the ischium (HP:0003174) | 1.52494108 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 1.50877827 |
| 68 | Genital tract atresia (HP:0001827) | 1.45772528 |
| 69 | Progressive sensorineural hearing impairment (HP:0000408) | 1.45392964 |
| 70 | Abnormal cartilage morphology (HP:0002763) | 1.45138523 |
| 71 | Severe Myopia (HP:0011003) | 1.43356700 |
| 72 | Portal hypertension (HP:0001409) | 1.40905193 |
| 73 | Pancreatic fibrosis (HP:0100732) | 1.39761752 |
| 74 | Chronic sinusitis (HP:0011109) | 1.33703446 |
| 75 | Complement deficiency (HP:0004431) | 1.32379236 |
| 76 | Dysdiadochokinesis (HP:0002075) | 1.32174100 |
| 77 | Epileptic encephalopathy (HP:0200134) | 1.32096050 |
| 78 | Postural tremor (HP:0002174) | 1.29843597 |
| 79 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.29200727 |
| 80 | Hypoplasia of the uterus (HP:0000013) | 1.27668208 |
| 81 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.26487577 |
| 82 | Febrile seizures (HP:0002373) | 1.25428113 |
| 83 | Abnormality of the parathyroid morphology (HP:0011766) | 1.23664557 |
| 84 | Abnormality of the hepatic vasculature (HP:0006707) | 1.23172934 |
| 85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.23168003 |
| 86 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.23151375 |
| 87 | Conjunctival telangiectasia (HP:0000524) | 1.19614355 |
| 88 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.18972111 |
| 89 | Pulmonary artery stenosis (HP:0004415) | 1.16972293 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 1.16830745 |
| 91 | Hydroxyprolinuria (HP:0003080) | 1.16830745 |
| 92 | Abdominal situs inversus (HP:0003363) | 1.16156902 |
| 93 | Abnormality of abdominal situs (HP:0011620) | 1.16156902 |
| 94 | Rhinitis (HP:0012384) | 1.15179024 |
| 95 | Hypoalphalipoproteinemia (HP:0003233) | 1.14716218 |
| 96 | Cystic liver disease (HP:0006706) | 1.14524093 |
| 97 | Spontaneous hematomas (HP:0007420) | 1.13409474 |
| 98 | Pancreatic cysts (HP:0001737) | 1.12939397 |
| 99 | Abnormality of the nasal septum (HP:0000419) | 1.11724707 |
| 100 | Abnormal pupillary function (HP:0007686) | 1.11649869 |
| 101 | Pheochromocytoma (HP:0002666) | 1.09814370 |
| 102 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.09683166 |
| 103 | Astigmatism (HP:0000483) | 1.08467092 |
| 104 | Complete atrioventricular canal defect (HP:0001674) | 1.07964628 |
| 105 | Abnormality of the fovea (HP:0000493) | 1.07592760 |
| 106 | Steppage gait (HP:0003376) | 1.07345918 |
| 107 | Cubitus valgus (HP:0002967) | 1.07269253 |
| 108 | Bicornuate uterus (HP:0000813) | 1.07149413 |
| 109 | Hypoplasia of the fovea (HP:0007750) | 1.05275388 |
| 110 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.05275388 |
| 111 | Oligodactyly (hands) (HP:0001180) | 1.04168769 |
| 112 | Progressive cerebellar ataxia (HP:0002073) | 1.04003434 |
| 113 | Deep philtrum (HP:0002002) | 1.03802387 |
| 114 | Recurrent sinusitis (HP:0011108) | 1.02891802 |
| 115 | Hyperkalemia (HP:0002153) | 1.02718831 |
| 116 | Calf muscle hypertrophy (HP:0008981) | 1.02010277 |
| 117 | Bronchomalacia (HP:0002780) | 1.01737214 |
| 118 | Truncal ataxia (HP:0002078) | 1.00155786 |
| 119 | Chorioretinal coloboma (HP:0000567) | 0.98633524 |
| 120 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.94460418 |
| 121 | Sclerocornea (HP:0000647) | 0.91986543 |
| 122 | Specific learning disability (HP:0001328) | 0.90234247 |
| 123 | Broad foot (HP:0001769) | 0.90194136 |
| 124 | Left ventricular hypertrophy (HP:0001712) | 0.89186737 |
| 125 | Genetic anticipation (HP:0003743) | 0.88749936 |
| 126 | Hypermetropia (HP:0000540) | 0.85099073 |
| 127 | Broad-based gait (HP:0002136) | 0.83670733 |
| 128 | Asthma (HP:0002099) | 0.82952625 |
| 129 | Abnormality of dental color (HP:0011073) | 0.82868911 |
| 130 | Abnormality of midbrain morphology (HP:0002418) | 0.82289703 |
| 131 | Molar tooth sign on MRI (HP:0002419) | 0.82289703 |
| 132 | Furrowed tongue (HP:0000221) | 0.81464310 |
| 133 | Chronic hepatic failure (HP:0100626) | 0.80586672 |
| 134 | Visual hallucinations (HP:0002367) | 0.79643040 |
| 135 | Decreased testicular size (HP:0008734) | 0.79515732 |
| 136 | Prolonged QT interval (HP:0001657) | 0.78468461 |
| 137 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.78333908 |
| 138 | * Retinal detachment (HP:0000541) | 0.75808830 |
| 139 | Hyperventilation (HP:0002883) | 0.74482105 |
| 140 | Aqueductal stenosis (HP:0002410) | 0.74258003 |
| 141 | Abnormality of the fingertips (HP:0001211) | 0.74149096 |
| 142 | Anencephaly (HP:0002323) | 0.73964183 |
| 143 | Corneal dystrophy (HP:0001131) | 0.69796142 |
| 144 | Macroorchidism (HP:0000053) | 0.69747299 |
| 145 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.69574641 |
| 146 | Lymphopenia (HP:0001888) | 0.69532721 |
| 147 | Congenital hepatic fibrosis (HP:0002612) | 0.68985292 |
| 148 | Gaze-evoked nystagmus (HP:0000640) | 0.66902284 |
| 149 | Postaxial hand polydactyly (HP:0001162) | 0.66511308 |
| 150 | Abnormal EKG (HP:0003115) | 0.65870378 |
| 151 | Cerebellar dysplasia (HP:0007033) | 0.64847844 |
| 152 | Short foot (HP:0001773) | 0.62705791 |
| 153 | Nephronophthisis (HP:0000090) | 0.62329599 |
| 154 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.62286217 |
| 155 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.62103707 |
| 156 | Dental crowding (HP:0000678) | 0.60831356 |
| 157 | Hypodontia (HP:0000668) | 0.60617420 |
| 158 | Postaxial foot polydactyly (HP:0001830) | 0.59032256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.67304386 |
| 2 | PINK1 | 2.90930238 |
| 3 | STK24 | 2.51666233 |
| 4 | IRAK2 | 2.11492554 |
| 5 | MST4 | 2.06696009 |
| 6 | GRK1 | 11.5590905 |
| 7 | PIK3CG | 1.96521527 |
| 8 | BRD4 | 1.89936841 |
| 9 | SIK2 | 1.85425477 |
| 10 | CAMK1G | 1.82033175 |
| 11 | INSRR | 1.79205806 |
| 12 | ADRBK1 | 1.72126471 |
| 13 | MAPK7 | 1.62883807 |
| 14 | STK39 | 1.56961775 |
| 15 | CDK12 | 1.50624409 |
| 16 | CAMK1D | 1.48286520 |
| 17 | TAOK3 | 1.44695905 |
| 18 | MAPK12 | 1.37598381 |
| 19 | BMPR1B | 1.35927440 |
| 20 | OBSCN | 1.33657124 |
| 21 | TTN | 1.29106622 |
| 22 | HIPK2 | 1.26242260 |
| 23 | MAP3K10 | 1.24918125 |
| 24 | MAP3K4 | 1.23185577 |
| 25 | SGK494 | 1.21702148 |
| 26 | SGK223 | 1.21702148 |
| 27 | EPHA3 | 1.21315384 |
| 28 | STK38 | 1.21004833 |
| 29 | PNCK | 1.20318840 |
| 30 | TIE1 | 1.18075586 |
| 31 | SGK2 | 1.14287816 |
| 32 | AKT3 | 1.12030266 |
| 33 | MET | 1.11672276 |
| 34 | PLK4 | 1.09770945 |
| 35 | PTK2B | 1.09458685 |
| 36 | CCNB1 | 1.05582692 |
| 37 | PAK6 | 1.05483185 |
| 38 | CSNK1D | 1.04343313 |
| 39 | MARK1 | 1.04308079 |
| 40 | EPHB2 | 1.01381208 |
| 41 | TGFBR2 | 1.00656748 |
| 42 | STK38L | 0.97377239 |
| 43 | PRKCH | 0.96878449 |
| 44 | BRSK2 | 0.96811164 |
| 45 | ICK | 0.96074437 |
| 46 | TRIM28 | 0.94931232 |
| 47 | SGK3 | 0.94007845 |
| 48 | EPHB1 | 0.94004238 |
| 49 | MAP3K3 | 0.92516543 |
| 50 | PRKCZ | 0.92423489 |
| 51 | CDK3 | 0.89065038 |
| 52 | TRPM7 | 0.87168037 |
| 53 | ERBB2 | 0.86512461 |
| 54 | FER | 0.81987873 |
| 55 | WNK1 | 0.80327528 |
| 56 | RPS6KA4 | 0.78931370 |
| 57 | MST1R | 0.77554331 |
| 58 | MYLK | 0.74329471 |
| 59 | ACVR1B | 0.73703124 |
| 60 | TESK1 | 0.73133549 |
| 61 | WNK4 | 0.72808656 |
| 62 | PRKCB | 0.72422648 |
| 63 | CASK | 0.72077728 |
| 64 | PRKD3 | 0.71916573 |
| 65 | MAP2K7 | 0.68903891 |
| 66 | CAMKK1 | 0.68376888 |
| 67 | TTK | 0.68180220 |
| 68 | PRKG2 | 0.67533723 |
| 69 | CAMKK2 | 0.67147319 |
| 70 | LATS1 | 0.67049468 |
| 71 | PLK2 | 0.67011069 |
| 72 | CAMK2D | 0.66801643 |
| 73 | PRKAA2 | 0.66506077 |
| 74 | GRK5 | 0.65250772 |
| 75 | DYRK1A | 0.65082964 |
| 76 | FES | 0.63728619 |
| 77 | OXSR1 | 0.63021804 |
| 78 | MAPKAPK3 | 0.62299557 |
| 79 | NTRK3 | 0.61343314 |
| 80 | PRKAA1 | 0.60574730 |
| 81 | MAP3K9 | 0.60132311 |
| 82 | MAPK15 | 0.58525212 |
| 83 | PRKACG | 0.57242627 |
| 84 | SGK1 | 0.56786092 |
| 85 | BRAF | 0.56719969 |
| 86 | CAMK1 | 0.56675860 |
| 87 | PKN2 | 0.55984449 |
| 88 | RPS6KA3 | 0.55668110 |
| 89 | CDK9 | 0.55380178 |
| 90 | NEK6 | 0.54720146 |
| 91 | PRKD2 | 0.53440236 |
| 92 | DDR2 | 0.51775648 |
| 93 | FRK | 0.51707478 |
| 94 | LMTK2 | 0.51524166 |
| 95 | STK11 | 0.50029037 |
| 96 | PHKG1 | 0.48581034 |
| 97 | PHKG2 | 0.48581034 |
| 98 | CDK5 | 0.47892367 |
| 99 | PKN1 | 0.46141390 |
| 100 | PRPF4B | 0.45962583 |
| 101 | MUSK | 0.45621593 |
| 102 | CAMK4 | 0.44899279 |
| 103 | AKT2 | 0.44530349 |
| 104 | NEK2 | 0.43978598 |
| 105 | MTOR | 0.43845079 |
| 106 | CAMK2A | 0.43683351 |
| 107 | PRKCE | 0.43654380 |
| 108 | PTK2 | 0.43618636 |
| 109 | GSK3B | 0.43572863 |
| 110 | ILK | 0.41553762 |
| 111 | PRKDC | 0.40073435 |
| 112 | MAPK14 | 0.39331710 |
| 113 | RPS6KB2 | 0.39040933 |
| 114 | TGFBR1 | 0.38748952 |
| 115 | DYRK1B | 0.38703989 |
| 116 | MAP3K7 | 0.38647667 |
| 117 | PRKCG | 0.36774951 |
| 118 | MAPK10 | 0.36628436 |
| 119 | PRKD1 | 0.36005115 |
| 120 | BRSK1 | 0.35940597 |
| 121 | ARAF | 0.35813561 |
| 122 | MAPK9 | 0.35722259 |
| 123 | STK3 | 0.35292877 |
| 124 | PLK3 | 0.35147905 |
| 125 | PRKACA | 0.34470832 |
| 126 | YES1 | 0.34354006 |
| 127 | WEE1 | 0.34334624 |
| 128 | SIK3 | 0.33113537 |
| 129 | SIK1 | 0.32350026 |
| 130 | CDC42BPA | 0.32324259 |
| 131 | MAP2K4 | 0.32223675 |
| 132 | MKNK2 | 0.31893178 |
| 133 | NTRK2 | 0.31365243 |
| 134 | MAP3K13 | 0.30507028 |
| 135 | FGFR2 | 0.30103593 |
| 136 | CDK1 | 0.29440124 |
| 137 | RPS6KB1 | 0.28820969 |
| 138 | MINK1 | 0.28708888 |
| 139 | PRKCA | 0.27584032 |
| 140 | EPHA4 | 0.27279010 |
| 141 | NUAK1 | 0.25787045 |
| 142 | PAK3 | 0.24673787 |
| 143 | PIK3CA | 0.24264689 |
| 144 | PRKCI | 0.23635575 |
| 145 | CHEK2 | 0.23127170 |
| 146 | JAK1 | 0.23085492 |
| 147 | MAPK3 | 0.21752221 |
| 148 | MAP2K1 | 0.19731213 |
| 149 | MAPK8 | 0.19683116 |
| 150 | SRC | 0.18828819 |
| 151 | PRKG1 | 0.18591596 |
| 152 | FYN | 0.18359519 |
| 153 | PAK2 | 0.18294271 |
| 154 | ERBB4 | 0.15669772 |
| 155 | PRKCQ | 0.15375541 |
| 156 | TAF1 | 0.15257102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 15.9432457 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.53694811 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.50904537 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 1.50519272 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28740283 |
| 6 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.20316507 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 1.14705144 |
| 8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14131922 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04923655 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01418373 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98914762 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93107897 |
| 13 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91655168 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.86039374 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85620624 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 0.85197462 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83425633 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82654874 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82611725 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82582361 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80668977 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78398608 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76153139 |
| 24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75750597 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74384292 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71704250 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70018626 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65774046 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64606020 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 0.64168245 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63616237 |
| 32 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61570907 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 0.59220690 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58784564 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58750360 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54884457 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54821107 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53119630 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53110077 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52550606 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52467784 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51467738 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49770932 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49272122 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48021195 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46758694 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45641718 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45525236 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 0.44744261 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44210972 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44093967 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43583441 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41474035 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41132849 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39926644 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39224555 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39145981 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38918976 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38758741 |
| 60 | Melanoma_Homo sapiens_hsa05218 | 0.38557754 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38113160 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37916234 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.37430970 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37273293 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36504131 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36032458 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35839597 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35681138 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.35108939 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33827277 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33547809 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33188122 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32988859 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32886747 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32514976 |
| 76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31214875 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.30965298 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29443135 |
| 79 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28911675 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28710896 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.28375614 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27069559 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27017464 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27004287 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26869239 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.26675658 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.26614330 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26163786 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25977482 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25307729 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25290335 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24374522 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.24340137 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23964191 |
| 95 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.23856557 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23549256 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.23520256 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22658850 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22200055 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.21355004 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.21013101 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.20897905 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.20707513 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.20259875 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20088186 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19543958 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.18185036 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17813275 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.17143800 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.16565335 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15365331 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.15256526 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14476195 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14134620 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.13944205 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13811243 |
| 117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13614160 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13609916 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13475209 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13450824 |
| 121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12356302 |
| 122 | Alcoholism_Homo sapiens_hsa05034 | 0.12318596 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.11442982 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11320969 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.09945290 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.09486764 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09398350 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09308598 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.08722009 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.08537087 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.07638838 |
| 132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.07534630 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07450762 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.07201698 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06917177 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06529810 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.06126449 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05536773 |
| 139 | Axon guidance_Homo sapiens_hsa04360 | 0.05030360 |
| 140 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04021476 |
| 141 | Melanogenesis_Homo sapiens_hsa04916 | 0.03843402 |
| 142 | Galactose metabolism_Homo sapiens_hsa00052 | 0.03806578 |
| 143 | Long-term depression_Homo sapiens_hsa04730 | 0.03459063 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.02959369 |
| 145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.02883037 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.02826611 |
| 147 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.01924395 |
| 148 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.01919734 |

